Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

XTRA:BST
XTRA:BSTMedia

Bastei Lübbe (XTRA:BST) Q3 EPS Softness Tests Bullish Growth Narratives

Bastei Lübbe (XTRA:BST) has released its Q3 2026 scorecard with revenue of €35.223 million and basic EPS of €0.21, alongside net income of €2.772 million that keeps the year running steadily. The company has seen revenue move from €30.155 million in Q2 2025 to €33.956 million in Q3 2025 and then to €35.223 million in Q3 2026. Over the same three quarters, basic EPS has been €0.26, €0.31 and now €0.21, giving investors data points to weigh the earnings path against margins and to assess how...
OM:ENITY
OM:ENITYDiversified Financial

Enity Holding (OM:ENITY) Earnings Growth Of 33.6% Tests Valuation Concerns

Enity Holding (OM:ENITY) has wrapped up FY 2025 with fourth quarter revenue of SEK305.8 million and EPS of SEK2.13, rounding out a year where trailing twelve month revenue reached SEK1.21 billion and EPS landed at SEK10.65. Over recent periods the company has seen quarterly revenue move from SEK274.8 million in Q4 2024 to SEK305.8 million in Q4 2025, while quarterly EPS shifted from SEK0.28 to SEK2.13. This sets the stage for investors to focus on how its 28% trailing net profit margin frames...
NasdaqGS:SFM
NasdaqGS:SFMConsumer Retailing

A Look At Sprouts Farmers Market (SFM) Valuation As It Enters The New York Market

New York entry: why Centereach matters for Sprouts Farmers Market (SFM) Sprouts Farmers Market (SFM) is entering New York with a new store in Centereach, Long Island, opening January 30. This expansion puts the grocer into a large, highly competitive food retail market. See our latest analysis for Sprouts Farmers Market. At a share price of US$66.34, Sprouts Farmers Market has recently seen a 4.52% 1 day share price decline and a 17.73% year to date share price decline. Its 1 year total...
NYSE:APTV
NYSE:APTVAuto Components

Weighing Aptiv (APTV) After Mixed Returns And Conflicting Valuation Signals

If you are wondering whether Aptiv's current share price lines up with its underlying value, you are not alone. This article is designed to help you frame that question clearly. Aptiv's stock last closed at US$79.72, with returns of 1.1% over 7 days, a 3.5% decline over 30 days, 1.6% year to date, a 25.6% gain over 1 year, and declines of 31.3% and 48.2% over 3 and 5 years respectively. Taken together, these figures give a mixed signal about growth potential and risk perception. Recent...
ASX:BGL
ASX:BGLMetals and Mining

Bellevue Gold (ASX:BGL) Valuation After Fresh Buy Ratings And Strong Quarterly Cash Flow

Multiple brokers have recently reiterated positive views on Bellevue Gold (ASX:BGL) after the miner reported strong operating cash flow, higher cash reserves, increased output and rising grades in its latest quarter. See our latest analysis for Bellevue Gold. The latest quarterly update and renewed broker interest come after a mixed price patch, with a 1 day share price return of a 4.89% decline and a 7 day share price return of a 12.20% decline. However, the 90 day share price return of...
NYSE:GOLD
NYSE:GOLDRetail Distributors

Tether Goldcom Deal Connects Stablecoins With Physical Bullion Investors

Tether has invested in and partnered with Gold.com, the parent company of NYSE:GOLD, to integrate tokenized gold into its platform. The collaboration will allow customers to use stablecoins to purchase physical gold through Gold.com. The move links a major stablecoin issuer with a large gold company, connecting blockchain based assets with physical bullion markets. For investors watching NYSE:GOLD, this partnership sits at the crossroads of traditional commodities and digital assets...
NasdaqGM:GPCR
NasdaqGM:GPCRPharmaceuticals

Structure Therapeutics’ Oral Obesity Drug Enters Phase 2 As Investor Focus Grows

Structure Therapeutics (NasdaqGM:GPCR) has advanced its lead obesity candidate GSBR-1290 into phase 2 clinical trials as an oral treatment. The move comes as the company draws increased attention for targeting the obesity market with a pill-based approach rather than injectables. Analyst optimism and early discussion about potential takeovers have put fresh focus on the stock. Structure Therapeutics, trading under NasdaqGM:GPCR, is drawing fresh interest after pushing GSBR-1290 into phase...
NYSE:RH
NYSE:RHSpecialty Retail

Will RH’s (RH) Earnings Beat and Leadership Shift Reshape Its Experiential Luxury Narrative?

RH recently reported third-quarter 2025 results showing year-over-year revenue growth and continued market share gains, alongside progress in expanding its gallery footprint and experiential concepts such as the RH Interior Design office and RH Ocean Grill. A separate development saw the departure of Chief Gallery & Customer Officer Stefan Duban in January 2026, with his responsibilities redistributed across existing leadership, highlighting how RH aims to support its growth initiatives...
NasdaqGS:MKSI
NasdaqGS:MKSISemiconductor

Is MKS (MKSI) Quietly Rewriting Its Capital Structure For Greater Strategic Freedom?

MKS Inc. recently closed a private offering of €1.00 billion in 4.250% senior unsecured notes due 2034 and refinanced portions of its term loans and revolving credit facility, extending key maturities into the next decade and reducing interest margins on its dollar and euro borrowings. By replacing part of its secured term loan with unsecured notes and lowering interest costs, MKS has reshaped its capital structure in a way that may ease future financing pressure and improve financial...
BIT:ANIM
BIT:ANIMCapital Markets

A Look At Anima Holding (BIT:ANIM) Valuation After Full Year Results And Board Decisions

Anima Holding (BIT:ANIM) is in focus after its board met on February 4, 2026 to approve consolidated full year results and to prepare proposals tied to the 2025 financial report for shareholders. See our latest analysis for Anima Holding. The earnings release and board meeting appear to have coincided with building momentum in the shares, with a 14.84% 1 month share price return and a 15.41% year to date move. The 3 year total shareholder return of 116.72% signals a strong longer term...
OM:PNDX B
OM:PNDX BReal Estate

Pandox (OM:PNDX B) EPS Surge Reinforces Bullish Narratives Despite Valuation Debate

Pandox (OM:PNDX B) has just wrapped up FY 2025 with Q4 revenue of SEK 2,076 million and Basic EPS of SEK 8.68, while trailing twelve month revenue came in at SEK 7,469 million with Basic EPS of SEK 16.13. Over the past few quarters, the company has seen revenue move from SEK 1,518 million in Q1 2025 to SEK 1,903 million in Q2, SEK 1,972 million in Q3 and SEK 2,076 million in Q4, with quarterly EPS ranging from SEK 0.58 to SEK 8.68 and trailing twelve month EPS rising from SEK 6.77 in Q2 2025...
OM:AFRY
OM:AFRYProfessional Services

Afry (OM:AFRY) Margin Compression To 3.1% TTM Tests Bullish Growth Narratives

Afry (OM:AFRY) has wrapped up FY 2025 with Q4 revenue of SEK 6,647 million and basic EPS of SEK 1.94, while trailing twelve month EPS came in at SEK 7.06 on revenue of SEK 25,758 million and net income of SEK 800 million. Over the past six reported quarters, revenue has ranged from SEK 5,687 million to SEK 7,084 million, with quarterly EPS moving between SEK 1.21 and SEK 3.07. This gives investors a clear look at how earnings power has tracked alongside a net margin that has eased over the...
NYSE:MOH
NYSE:MOHHealthcare

Has The Market Gone Too Far In Marking Down Molina Healthcare (MOH) Shares?

If you are trying to figure out whether Molina Healthcare's share price reflects its true worth, the starting point is understanding how its current market price compares with a range of valuation checks. The stock last closed at US$176.84, with returns of a 4.4% decline over 7 days, 4.3% decline over 30 days, 0.9% decline year to date, 38.0% decline over 1 year, 41.3% decline over 3 years, and 18.2% decline over 5 years, which may have shifted how investors see its potential and its...
NasdaqGS:QCOM
NasdaqGS:QCOMSemiconductor

Why QUALCOMM (QCOM) Is Down 10.5% After Record Q1 Results But Cautious Memory‑Supply Guidance

In early February 2026, Qualcomm reported record fiscal first‑quarter revenue of US$12.25 billion and net income of US$3.00 billion, but issued weaker second‑quarter guidance due to a global memory chip shortage constraining smartphone production. Alongside the earnings release, Qualcomm highlighted that strong demand for premium handsets and growing automotive and IoT contributions are being held back by supply bottlenecks rather than a lack of end‑market interest. We’ll now look at how...
SEHK:23
SEHK:23Banks

How Investors May Respond To Bank of East Asia (SEHK:23) Scaling UiPath-Powered Automation Across Core Operations

Bank of East Asia has already embedded UiPath robotic process automation into its production operations and testing workflows, aiming to stabilise complex processes, reduce error rates, and improve data movement between systems while strengthening risk controls. The bank reports that these UiPath deployments have saved more than 553,000 aggregated processing hours and plans to expand automation through citizen development across the organisation, highlighting how deeply automation is being...
NasdaqGS:TECH
NasdaqGS:TECHLife Sciences

Bio Techne (TECH) Margin Compression To 6.7% TTM Tests Bullish Growth Narratives

Bio-Techne (TECH) has reported Q2 2026 revenue of US$295.9 million with basic EPS of US$0.24, alongside trailing twelve month revenue of about US$1.2 billion and EPS of US$0.52, setting up a mixed picture for growth and profitability. The company has seen quarterly revenue move between US$289.5 million and US$317.0 million over the past six reported periods, while basic EPS has ranged from a loss of US$0.11 to a recent run rate just above US$0.24. This matters for investors focused on how...
NYSE:VYX
NYSE:VYXSoftware

Assessing NCR Voyix (VYX) Valuation After Prolonged Share Price Weakness

Why NCR Voyix (VYX) Is On Investors’ Radar Today NCR Voyix (VYX) is drawing fresh attention after a period of weak share performance, with the stock around $9.47 and total return figures over the past year and past 3 months reflecting double digit declines. With revenue of about $2.65b and a reported net loss of $62 million, investors are evaluating how this digital commerce business, focused on retailers and restaurants across multiple regions, is managing the balance between growth...
ASX:NST
ASX:NSTMetals and Mining

Why Northern Star Resources (ASX:NST) Is Down 7.5% After Broker Upgrade Amid Rising Cost Guidance

In early February 2026, Northern Star Resources drew renewed attention after a major broker upgraded its rating, coinciding with a rebound in gold prices and heightened focus on the miner’s upcoming FY26 half-year results. Investor interest is increasingly centred on how Northern Star’s higher all-in sustaining cost guidance and revised production outlook will shape perceptions of its operational efficiency and cash generation. We’ll now examine how the broker upgrade, set against rising...
NYSE:TNC
NYSE:TNCMachinery

Tennant Sets 2026 Meeting Timeline As Undervalued Shares Show Steady Gains

Tennant Company set the date for its 2026 annual meeting of shareholders. The company also announced the deadline for shareholders to nominate director candidates for the 2026 board election. The update outlines the timetable that will guide board nominations and voting for NYSE:TNC. Tennant, trading on the NYSE under ticker NYSE:TNC, recently closed at $80.84. The stock is up 5.5% over the past week, 5.0% over the past month, and 9.3% year to date, while showing a 4.1% decline over the...
ASX:JIN
ASX:JINHospitality

A Look At Jumbo Interactive (ASX:JIN) Valuation After Strong FY26 Half Year Growth And Diversification

Jumbo Interactive (ASX:JIN) has drawn fresh attention after reporting first half FY26 revenue growth of 29% and underlying EBITDA growth of 22.6%, along with an updated dividend payout policy and ongoing diversification. See our latest analysis for Jumbo Interactive. Despite the solid first half update and recent acquisitions in prize-based giveaways, Jumbo Interactive’s recent momentum has been weak, with a 30 day share price return of 12.08% decline and a 1 year total shareholder return of...
NYSE:PHIN
NYSE:PHINAuto Components

Assessing PHINIA (PHIN) Valuation After Recent Share Price Momentum And Conflicting Fair Value Signals

PHINIA: recent returns and earnings context PHINIA (PHIN) has attracted attention after a recent period of positive share price performance, with the stock showing gains over the past week, month and past 3 months alongside reported revenue and net income figures. See our latest analysis for PHINIA. At a latest share price of US$71.08, PHINIA has seen a firm build up in momentum, with a 33.16% 3 month share price return and a 44.23% 1 year total shareholder return. These figures point to...
LSE:DGE
LSE:DGEBeverage

Diageo Brand Moves Test Premium Strength With Mixed Long Term Returns

Lagavulin has launched its first new permanent Scotch whisky in nine years, which has already received a major industry award. Guinness has introduced a charity focused lager in partnership with NFL legend Joe Montana, with proceeds linked to philanthropic causes. For investors watching Diageo (LSE:DGE), these launches sit against a mixed share price backdrop. The stock closed at £17.6 and is up 5.0% over the past week and 11.6% over the past month, with a 9.5% return year to date. Over...